Cannabis and Its Derivatives: Review of Medical Use

被引:64
|
作者
Leung, Lawrence [1 ]
机构
[1] Queens Univ, Dept Family Med, Kingston, ON K7L 5E9, Canada
关键词
Cannabis; Clinical Effects; Controversy; Drug Therapy; Marijuana; Substance Abuse; DELTA(9)-TETRAHYDROCANNABINOL THC; MYOCARDIAL-INFARCTION; MULTIPLE-SCLEROSIS; TOURETTES-SYNDROME; DOUBLE-BLIND; MARIJUANA; PAIN; SMOKING; DELTA-9-TETRAHYDROCANNABINOL; EFFICACY;
D O I
10.3122/jabfm.2011.04.100280
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Use of cannabis is often an under-reported activity in our society. Despite legal restriction, cannabis is often used to relieve chronic and neuropathic pain, and it carries psychotropic and physical adverse effects with a propensity for addiction. This article aims to update the current knowledge and evidence of using cannabis and its derivatives with a view to the sociolegal context and perspectives for future research. Methods: Cannabis use can be traced back to ancient cultures and still continues in our present society despite legal curtailment. The active ingredient, Delta 9-tetrahydrocannabinol, accounts for both the physical and psychotropic effects of cannabis. Though clinical trials demonstrate benefits in alleviating chronic and neuropathic pain, there is also significant potential physical and psychotropic side-effects of cannabis. Recent laboratory data highlight synergistic interactions between cannabinoid and opioid receptors, with potential reduction of drug-seeking behavior and opiate sparing effects. Legal rulings also have changed in certain American states, which may lead to wider use of cannabis among eligible persons. Conclusions: Family physicians need to be cognizant of such changing landscapes with a practical knowledge on the pros and cons of medical marijuana, the legal implications of its use, and possible developments in the future. (J Am Board Fam Med 2011;24:452-462.)
引用
收藏
页码:452 / 462
页数:11
相关论文
共 50 条
  • [41] Legalization of cannabis for medical and recreational use
    Hasin, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [42] Medical Cannabis Use in Han Dynasty
    Wiebrecht, Axel
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2021, 64 (03): : 225 - 225
  • [43] Legalization of cannabis for medical and recreational use
    Hasin, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S20 - S21
  • [44] Ethical issues in medical cannabis use
    Sagy, Iftach
    Peleg-Sagy, Tal
    Barski, Leonid
    Zeller, Lior
    Jotkowitz, Alan
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 49 : 20 - 22
  • [45] Use of Medical Cannabis for Respiratory Diseases
    Pechlivanidou, Rouzana
    Antoniadis, Andonis
    PNEUMON, 2018, 31 (02) : 67 - 70
  • [46] Simultaneous Cannabis and Alcohol Use among Medical Cannabis Patients
    Kritikos, Alexandra F.
    Johnson, Julie K.
    Hodgkin, Dominic
    SUBSTANCE USE & MISUSE, 2024, 59 (06) : 847 - 857
  • [47] Cannabis for medical purposes and its prescription
    Kiefer, Andreas
    Eckert-Lill, Christiane
    Bussick, Daniela
    Hoernig, Michael
    Reimann, Holger
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2019, 62 (07) : 811 - 817
  • [48] Demystifying Cannabis A Review of Its Pharmacology, Use in Pain, and Safety Concerns
    Dume, Roberta
    Lammers, Emily
    ORTHOPAEDIC NURSING, 2020, 39 (04) : 264 - 267
  • [49] Early cannabis use and its relation to the development of psychiatric disorders: a review
    Roncero, Carlos
    Felipe Palma-Alvarez, Raul
    Barrau, Victor
    Urbano, Neide
    Martinez-Luna, Nieves
    Bettina Ortiz-Medina, Maria
    Daigre, Constanza
    SALUD MENTAL, 2017, 40 (06) : 291 - 298
  • [50] Terpenes and terpenoids of cannabis: A medical review
    Troiani, Marco
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254